The usefulness of 18F-FDG PET/MRI fusion image in diagnosing pancreatic tumor: Comparison with 18F-FDG PET/CT

Annals of Nuclear Medicine

Volumn 27, Issue 6, 2013, Pages 554-563

  Nagamachi, Shigeki ^a   Nishii, Ryuichi ^a   Wakamatsu, Hideyuki ^a   Mizutani, Youichi ^a   Kiyohara, Shogo ^a   Fujita, Seigo ^a   Futami, Shigemi ^a   Sakae, Tatefumi ^a   Furukoji, Eiji ^a   Tamura, Shozo ^a   Arita, Hideo ^a   Chijiiwa, Kazuo ^a   Kawai, Keiichi ^b  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

18F FDG PET CT; 18F FDG PET MRI fusion image; Pancreatic tumor

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER DIAGNOSIS; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER PROGRAM; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; FEASIBILITY STUDY; FEMALE; HUMAN; IMAGE ANALYSIS; INOPERABLE CANCER; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PANCREAS CANCER; PANCREAS CYST; PANCREAS DUCT; PANCREAS TUMOR; PANCREATITIS; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOLOGIST; RETROSPECTIVE STUDY; TUMOR DIAGNOSIS; TUMOR INVASION;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIMODAL IMAGING; PANCREATIC NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84880816341     PISSN: 09147187     EISSN: 18646433     Source Type: Journal    
DOI: 10.1007/s12149-013-0719-3     Document Type: Article

References (48)

1. Murakami K. FDG-PET for hepatobiliary and pancreatic cancer: advances and current limitations. World J Clin Oncol. 2011;2:229-36.
2. Takanami K, Hiraide T, Tsuda M, Nakamura Y, Kaneta T, Takase K, et al. Additional value of FDG PET/CT to contrast-enhanced CT in the differentiation between benign and malignant intraductal papillary mucinous neoplasms of the pancreas with mural nodules. Ann Nucl Med. 2011;25:501-10.
3. Berberat P, Friess H, Kashiwagi M, Beger HG, Buchler MW. Diagnosis and staging of pancreatic cancer by positron emission tomography. World J Surg. 1999;23:882-7.
4. Nakamoto Y, Saga T, Ishimori T, Higashi T, Mamede M, Okazaki K, et al. FDG-PET of autoimmune-related pancreatitis: preliminary results. Eur J Nucl Med. 2000;27:1835-8.
5. Okano K, Kakinoki K, Akamoto S, Hagiike M, Usuki H, Yamamoto Y, et al. 18F-fluorodeoxyglucose positron emission tomography in the diagnosis of small pancreatic cancer. World J Gastroenterol. 2011;17:231-5.
6. Lyshchik A, Higashi T, Nakamoto Y, Fujimoto K, Doi R, Imamura M, et al. Dual-phase 18F-fluoro-2-deoxy-d-glucose positron emission tomography as a prognostic parameter in patients with pancreatic cancer. Eur J Nucl Med Mol Imaging. 2005;32:389-97.
7. Friess H, Langhans J, Ebert M, Beger HG, Stollfuss J, Reske SN, et al. Diagnosis of pancreatic cancer by 2[18F]-fluoro-2-deoxy-d-glucose positron emission tomography. Gut. 1995;36:771-7.
8. Stollfuss JC, Glatting G, Friess H, Kocher F, Berger HG, Reske SN. 2-(fluorine-18)-fluoro-2-deoxy-d-glucose PET in detection of pancreatic cancer: value of quantitative image interpretation. Radiology. 1995;195:339-44.
9. Higashi T, Saga T, Nakamoto Y, Ishimori T, Fujimoto K, Doi R, et al. Diagnosis of pancreatic cancer using fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) - usefulness and limitations in "clinical reality". Ann Nucl Med. 2003;17:261-79.
10. Schick V, Franzius C, Beyna T, Oei ML, Schnekenburger J, Weckesser M, et al. Diagnostic impact of 18F-FDG PET-CT evaluating solid pancreatic lesions versus endosonography, endoscopic retrograde cholangio-pancreatography with intraductal ultrasonography and abdominal ultrasound. Eur J Nucl Med Mol Imaging. 2008;35:1775-85.
11. Nguyen VX, Nguyen CC, Nguyen BD. (18)F-FDG PET/CT imaging of the pancreas: spectrum of diseases. J Pancreas 2011;12:557-66.
12. Nagamachi S, Wakamatsu H, Kiyohara S, Fujita S, Futami S, Arita H, et al. Usefulness of a deep-inspiration breath-hold 18F-FDG PET/CT technique in diagnosing liver, bile duct, and pancreas tumors. Nucl Med Commun. 2009;30:326-32.
13. Mergo PJ, Helmberger TK, Buetow PC, Helmberger RC, Ros PR. Pancreatic neoplasms: mR imaging and pathologic correlation. Radiographics. 1997;17:281-301.
14. Schlemmer HP, Pichler BJ, Krieg R, Heiss WD. An integrated MR/PET system: prospective applications. Abdom Imaging. 2009;34:668-74.
15. Schwenzer NF, Schraml C, Muller M, Brendle C, Sauter A, Spengler W, et al.: Pulmonary lesion assessment: comparison of whole-body hybrid MR/PET and PET/CT imaging - pilot study. Radiology. 2012;264:551-8.
16. Drzezga A, Souvatzoglou M, Eiber M, Beer AJ, Furst S, Martinez-Moller A, et al. first clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnoses. J Nucl Med. 2012;53:845-55.
17. Donati OF, Hany TF, Reiner CS, von Schulthess GK, Marincek B, Seifert B, et al. Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI. J Nucl Med. 2010;51:692-9.
18. Nakajo K, Tatsumi M, Inoue A, Isohashi K, Higuchi I, Kato H, et al. Diagnostic performance of fluorodeoxyglucose positron emission tomography/magnetic resonance imaging fusion images of gynecological malignant tumors: comparison with positron emission tomography/computed tomography. Jpn J Radiol. 2010;28:95-100.
19. Ruf J. Lopez Hanninen E, Bohmig M, Koch I, Denecke T, Plotkin M, et al.: Impact of FDG-PET/MRI image fusion on the detection of pancreatic cancer. Pancreatology. 2006;6:512-9.
20. Tatsumi M, Isohashi K, Onishi H, Hori M, Kim T, Higuchi I, et al. 18F-FDG PET/MRI fusion in characterizing pancreatic tumors: comparison to PET/CT. Int J Clin Oncol. 2011;16:408-15.
21. Miller FH, Keppke AL, Wadhwa A, Ly JN, Dalal K, Kamler VA. MRI of pancreatitis and its complications: part 2, chronic pancreatitis. Am J Roentgenol. 2004;183:1645-52.
22. Ros PR, Mortele KJ. Imaging features of pancreatic neoplasms. JBR-BTR. 2001;84:239-49.
23. Vitellas KM, Keogan MT, Spritzer CE, Nelson RC. MR cholangiopancreatography of bile and pancreatic duct abnormalities with emphasis on the single-shot fast spin-echo technique. Radiographics. 2000;20:939-57.
24. Buchs NC, Chilcott M, Poletti PA, Buhler LH, Morel P. Vascular invasion in pancreatic cancer: imaging modalities, preoperative diagnosis and surgical management. World J Gastroenterol. 2010;16:818-31.
25. Lu DS, Reber HA, Krasny RM, Kadell BM, Sayre J. Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT. Am J Roentgenol. 1997;168:1439-43.
26. Nakayama Y, Yamashita Y, Kadota M, Takahashi M, Kanemitsu K, Hiraoka T, et al. Vascular encasement by pancreatic cancer: correlation of CT findings with surgical and pathologic results. J Comput Assist Tomogr. 2001;25:337-42.
27. Li H, Zeng MS, Zhou KR, Jin DY, Lou WH. Pancreatic adenocarcinoma: the different CT criteria for peripancreatic major arterial and venous invasion. J Comput Assist Tomogr. 2005;29:170-5.
28. Arakawa A, Yamashita Y, Namimoto T, Tang Y, Tsuruta J, Kanemitsu K, et al. Intraductal papillary tumors of the pancreas. Histopathologic correlation of MR cholangiopancreatography findings. Acta Radiol. 2000;41:343-7.
29. Lopez HE, Amthauer H, Hosten N, Ricke J, Bohmig M, Langrehr J, et al. Prospective evaluation of pancreatic tumors: accuracy of MR imaging with MR cholangiopancreatography and MR angiography. Radiology. 2002;224:34-41.
30. Irie H, Honda H, Aibe H, Kuroiwa T, Yoshimitsu K, Shinozaki K, et al. MR cholangiopancreatographic differentiation of benign and malignant intraductal mucin-producing tumors of the pancreas. AJR Am J Roentgenol. 2000;174:1403-8.
31. Ardengh JC, Goldman SM, de Lima-Filho ER. Current role of imaging methods in the diagnosis of cystic solid pancreas neoplasms: part II. Rev Col Bras Cir. 2011;38:192-7.
32. Zimny M, Schumpelick V. Fluorodeoxyglucose positron emission tomography (FDG-PET) in the differential diagnosis of pancreatic lesions. Chirurg. 2001;72:989-94.
33. Sahani DV, Sainani NI, Deshpande V, Shaikh MS, Frinkelberg DL. Fernandez-del Castillo C: Autoimmune pancreatitis: disease evolution, staging, response assessment, and CT features that predict response to corticosteroid therapy. Radiology. 2009;250:118-29.
34. Hakime A, Giraud M, Vullierme MP, Vilgrain V. MR imaging of the pancreas. J Radiol. 2007;88:11-25.
35. Sugiyama M, Izumisato Y, Abe N, Masaki T, Mori T, Atomi Y. Pancreatic carcinoma that completely obstructs the Wirsung duct without dilatation of the main pancreatic duct. J Gastroenterol Hepatol. 2006;21:1154-6.
36. Takuma K, Kamisawa T, Gopalakrishna R, Hara S, Tabata T, Inaba Y, et al. Strategy to differentiate autoimmune pancreatitis from pancreas cancer. World J Gastroenterol. 2012;18:1015-20.
37. Sahani DV, Kalva SP, Farrell J, Maher MM, Saini S, Mueller PR, et al. Autoimmune pancreatitis: imaging features. Radiology. 2004;233:345-52.
38. Fischer MA, Donati O, Heinrich S, Weber A, Hany TF, Soldini D, et al. Intraductal oncocytic papillary neoplasm of the pancreas: a radio-pathological case study. J Pancreas. 2010;11:49-54.
39. Sperti C, Pasquali C, Chierichetti F, Liessi G, Ferlin G, Pedrazzoli S. Value of 18-fluorodeoxyglucose positron emission tomography in the management of patients with cystic tumors of the pancreas. Ann Surg. 2001;234:675-80.
40. Baiocchi GL, Portolani N, Bertagna F, Gheza F, Pizzocaro C, Giubbini R, et al. Possible additional value of 18FDG-PET in managing pancreas intraductal papillary mucinous neoplasms: preliminary results. J Exp Clin Cancer Res. 2008;27:10.
41. Ku YM, Shin SS, Lee CH, Semelka RC. Magnetic resonance imaging of cystic and endocrine pancreatic neoplasms. Top Magn Reson Imaging. 2009;20:11-8.
42. Kalb B, Sarmiento JM, Kooby DA, Adsay NV, Martin DR. MR imaging of cystic lesions of the pancreas. Radiographics. 2009;29:1749-65.
43. Pilleul F, Rochette A, Partensky C, Scoazec JY, Bernard P, Valette PJ. Preoperative evaluation of intraductal papillary mucinous tumors performed by pancreatic magnetic resonance imaging and correlated with surgical and histopathologic findings. J Magn Reson Imaging. 2005;21:237-44.
44. Schima W. MRI of the pancreas: tumours and tumour-simulating processes. Cancer Imaging. 2006;6:199-203.
45. Izuishi K, Yamamoto Y, Sano T, Takebayashi R, Masaki T, Suzuki Y. Impact of 18-fluorodeoxyglucose positron emission tomography on the management of pancreatic cancer. J Gastrointest Surg. 2010;14:1151-8.
46. Zhang XM, Mitchell DG, Witkiewicz A, Verma S, Bergin D. Extrapancreatic neural plexus invasion by pancreatic carcinoma: characteristics on magnetic resonance imaging. Abdom Imaging. 2009;34:634-41.
47. Mochizuki K, Gabata T, Kozaka K, Hattori Y, Zen Y, Kitagawa H, et al. MDCT findings of extrapancreatic nerve plexus invasion by pancreas head carcinoma: correlation with en bloc pathological specimens and diagnostic accuracy. Eur Radiol. 2010;20:1757-67.
48. Inagi E, Shimodan S, Amizuka H, Kigawa S, Shimizu Y, Nagashima K, et al. Pancreatic cancer initially presenting with a pseudocyst at the splenic flexure. Pathol Int. 2006;56:558-62.